Chronic antibody-mediated rejection: New diagnostic tools - clinical significance of C4d deposition and improved detection and characterization of human leucocyte antigen antibodies

Clinical and Experimental Immunology

Volumn 178, Issue S1, 2014, Pages 52-53

  Zeevi, A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; HLA ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN; PEPTIDE FRAGMENT;

ANTIBODY BLOOD LEVEL; ANTIBODY MEDIATED REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; COMPLEMENT ACTIVATION; GRAFT FAILURE; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; TRANSPLANTATION; ADVERSE EFFECTS; GRAFT REJECTION; IMMUNOLOGY; PROCEDURES;

ANTIBODIES; COMPLEMENT C4B; GRAFT REJECTION; HLA ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; TRANSPLANTATION;

EID: 84921506255     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12509     Document Type: Article

References (12)

1. Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 2012; 8:348-357.
2. Tait BD, Susal C, Gebel HM etal. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013; 95:19-47.
3. Feucht HE, Schneeberger H, Hillebrand G etal. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43:1333-1338.
4. Gaston RS, Cecka JM, Kasiske BL etal. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90:68-74.
5. Loupy A, Hill GS, Suberbielle C etal. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11:56-65.
6. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9:2312-2323.
7. Haas M, Sis B, Racusen LC etal. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14:272-283.
8. Chin C, Chen G, Sequeria F etal. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30:158-163.
9. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyan DB. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011; 91:342-347.
10. Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int 2012; 25:611-622.
11. Zeevi A, Lunz J, Feingold B etal. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant 2013; 32:98-105.
12. Loupy A, Lefaucheur C, Vernerey D etal. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013; 369:1215-1226.